or mail to 

 Fort Worth, TX 76114  

Recovery Reports

To see our latest

recovery reports

click here. 

We are contacted daily  

by people with chronic illnesses who are looking  

for an effective treatment. Many ask us to provide evidence of efficacy in the form of statistics or stories.  

If you have recovered your health or had significant symptom improvement with Inflammation Therapy (or a similar treatment), please  

help us 'pay it forward' by  

telling your story.  

We will post it in the public section of our website to encourage others.  

Any report, short  

or long, with or without objective data (e.g., lab results, imaging reports) would be helpful.   

Please email your story.

Thank you!  

CIR Library Access

Have you enjoyed this newsletter?

HONcode

The Internet has become an important communication tool but it isn't always easy to tell which information  

is reliable.  

When it comes to your health, it's important to be sure you're accessing a credible source.  

has certified that the

Greetings! 

 

Our annual Patient Workshop provided many opportunities for learning, support and socialization. Here are a few comments:

 

"Thank you for the workshop in Dallas. The presentations were so so informative and I really enjoyed the speakers. (so did my husband) I learned so much valuable information that I feel highly motivated and hopeful with the program." Donovan

"Four years ago I started my therapy. I went to a CIR conference because I wanted to understand things better and be sure this was the right way to go.  I was totally convinced after talking to other patients and hearing how Inflammation Therapy changed their lives and how they got better.  At my first conference I remember being concerned about how I would be able to cope with the increased pain of traveling, doing a lot of walking and sitting all day at a conference.  And yes I suffered for it, but it was worth it.  I just returned from the 2014 conference and it really hit home how much I have recovered." Kat

 

"Thanks for putting on a wonderful conference. There is nothing like being there and meeting other who "have been there". Nothing can replace that human interaction especially when you feel so isolated to begin with." Kathryn

 

We're exploring new locations for next year to give more people an opportunity to attend and we hope to see you there!  

     

Dysregulated Vitamin D Metabolism  

Causes Low Serum 25(OH)D

In the healthy individual, the complex interplay between innate and adaptive immunity cooperates to mount an appropriate response to infection through regulation of the vitamin D endocrine system.[1] Theoretically, the immune system detects and responds to the presence of cell wall deficient (CWD) bacteria by producing more 1,25(OH)2D to activate the VDR and express the crucial endogenous antimicrobial peptides (AMPs) which enable the innate immune system to target intracellular pathogens.[2] Renal production of 1,25(OH)2D is tightly self-regulated, with the end product down-regulating its own further production. In contrast, extra-renal tissues (e.g., uterine decidua and placenta, bone cells, keratinocytes, colon, breast, prostate, spleen, melanoma cells, synovial, and pulmonary monocytes and macrophages, etc.) which produce 1,25(OH)2D are regulated by cytokines (e.g., interferon-gamma), lipopolysaccharide (an inflammatory molecule), nitric oxide (NO is given off by dying bacteria) and intracellular VDBP (the precursor for the principal macrophage activating factor (MAF)), which activate the enzyme CYP27B1 to stimulate conversion of 25(OH)D to 1,25(OH)2D.[3] Data suggest that local synthesis of 1,25(OH)2D may be a preferred mode of response to antigenic challenge in many tissues and locally synthesized 1,25(OH)2D has the potential to spill-over into the general circulation.[4] This extra-renal production of 1,25(OH)2D in tissues infected with intracellular bacteria can result in an excess production of 1,25(OH)2D which may contribute to depletion and low levels of 25(OH)D.[5]

Because extra-renal production of 1,25(OH)2D is primarily dependent on the availability of 25(OH)D, supplementation with vitamin D to increase 25(OH)D may promote the production of 1,25(OH)2D in non-renal tissues that are sites of intracellular infection and result in hypervitaminosis-D.[6]Sunlight appears to play a part in this process. Vanderschueren et al. observed seasonal variations in 1,25(OH)2D at all levels of 25(OH)D and concluded that sunlight exposure appears to have an influence on 1,25(OH)2D very similar to that of 25(OH)D.[7] The skin (dermal fibroblasts and keratinocytes possess VDR) has the capacity to synthesize 1,25(OH)2D, and represents an important target tissue for 1,25(OH)2D.[8] If keratinocytes in the skin are infected, natural regulation of photosynthesis may be thwarted and solar energy may overstimulate cellular activity, resulting in an increase in cutaneous production of vitamin D3, 25(OH)D and 1,25(OH)2D following sun exposure.

When nucleated cells are parasitized by CWD bacteria, extra-renal production of 1,25(OH)2D increases,the kidneys lose control of 1,25(OH)2D production, and pro-hormone 25(OH)D decreases due to rapid conversion to 1,25(OH)2D. The following mechanisms are thought to be responsible:  

• Inflammatory cytokines activate CYP27B1 (formerly 1a-hydroxylase), an enzyme that causes more 25(OH)D to be converted to 1,25(OH)2D.[9]
• The microbial-repressed VDR can't transcribe CYP24A1 (formerly 24-hydroxylase), an enzyme that breaks down excess 1,25(OH)2D.[10]
• Excess 1,25(OH)2D binds the pregnane X receptor( PXR), to inhibit conversion of vitamin D3 to 25(OH)D so 25(OH)D is down-regulated.[11]
• 1,25(OH)2D inhibits the hepatic synthesis of 25(OH)D.[12]

Thus, low 25(OH)D may be a consequence of the inflammatory process. More studies are concluding that suboptimal circulating levels of vitamin D appear to be caused by the disease process. Waldrun et al. found serum 25(OH)D was decreased following an acute inflammatory insult (i.e., orthopedic surgery) and concluded hypovitaminosis D may be the consequence rather than cause of chronic inflammatory diseases.[13] Ferder et al. stated:  ...there may be a relationship between inflammatory processes induced by chronic overstimulation of the renin angiotensin system (RAS) and the worldwide vitamin D deficiency... In fact, the pandemic of vitamin D deficiency could be the other face of increased RAS activity, which could potentially cause a lower activity or lower levels of Vitamin D.[14]

1. Norman A. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Amer J Clin Nutr. Aug 2008;88(2):491S-499S.
2. Rasmussen SB, Reinert LS, Paludan SR. Innate recognition of intracellular pathogens: detection and activation of the first line of defense. APMIS. May 2009(117(5-6)):323-37.
3. Dusso AS, Kamimura S, Gallieni M, et al. gamma-Interferon-induced resistance to 1,25-(OH)2D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab. 1997;82(7):2222-32.
4. Hewison M, Burke F, Evans KN, et al. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):316-21.
5. Edfeldt K, Liu PT, Chun R, et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A. Dec 2010;107(52):22593-8.
6. Lambert PW, Stern PH, Avioli RC, et al. Evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D in man. J Clin Invest. Mar 1982;69(3):722-5.
7. Vanderschueren D, Pye SR, O'Neill TW, et al. Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS). J Clin Endocrinol Metab. Mar 2013;98(3):995-1005.
8. Reichrath J. Vitamin D and the skin: an ancient friend, revisited. Exp Dermatol. Jul 2007;16(7):618-25.
9. Bikle DD. Vitamin D and immune function: understanding common pathways. Curr Osteoporos Rep. Jul 2009;7(2):58-63.
10. Jones G, Prosser DE, Kaufman M. 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): Its important role in the degradation of vitamin D. Arch Biochem Biophys. Jul 2012;523(1)(9-18):9-18.
11. Xu Y, Hashizume T, Shuhart MC, et al. Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia. Mol Pharmacol. Jan 2006;69(1):56-65.
12. Bell NH, Shaw S, Turner RT. Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest. Oct 1984;74(4):1540-4.
13. Waldron JL, Ashby HL, Cornes MP, et al. Vitamin D: a negative acute phase reactant. J Clin Pathol. Mar 2013;[Epub ahead of print].
14. Ferder M, Inserra F, Manucha W, Ferder L. The world pandemic of Vitamin D deficit could possibly be explained by cellular inflammatory response activity induced by the renin angiotensin system. Am J Physiol Cell Physiol. Jan 2013;[Epub ahead of print]. 

An increasing number of physicians are using Inflammation Therapy (IT) to treat chronic illness. Because this unique medical regime causes a temporary exacerbation of symptoms, medical practitioners need help to understand the nuances of the recovery process and keep the expected immune system reactions under control. Working with patients who are on IT has been the most effective means of gaining an understanding of how to introduce and adjust the therapy medications to maintain tolerable symptoms and ensure patient safety.

To that end, Chronic Illness Recovery has created a private forum to provide a vehicle for RNs to counsel patients while working closely with their physicians. Professional nurses, experienced with counseling patients on IT, monitor and advise patients through the recovery process while keeping their doctor informed each step of the way.

If you would like to enroll in the CIR counseling program, please send a request for an enrollment form to info@chronicillnessrecovery.org  

or call us at 1-888-846-2474 (toll-free in the US and Canada). You will be sent information by email to tell you more about the program and how to enroll.